EGFR and neoplasm: MUC4’s juxtamembrane EGF-like domains are responsible for preventing EGFR ubiquitination and degradation upon ligand stimulation, which allows for persistent activation of downstream signaling pathways essential for tumor development, such as the ERK and PI3K/Akt pathways (168).